Aliment Pharmacol Ther 30, 791–815 Summary Background Helicobacter pylori infection
rates in duodenal ulcer (DU) patients may be lower than previously estimated. Aim To …

The presence of concomitant diseases is an independent predictive factor for non-
Helicobacter pylori (H. pylori) peptic ulcers. Patients contracting concomitant diseases have …

Background The role of Helicobacter pylori eradication to cure peptic ulcer disease in
patients with cirrhosis is not clear. Aim To investigate the course of peptic ulcer disease in …

Background: Helicobacter pylori (H. pylori) plays an important role in causing peptic ulcer
disease (PUD) in the general population. However, the role of H. pylori in cirrhotic patients …

BACKGROUND/AIMS: Peptic ulcers occur more commonly in patients with liver cirrhosis
(LC). Helicobacter pylori is recognized as the most important etiology in the pathogenesis of …

BACKGROUND There is significant heterogeneity between gastroesophageal varices
(GOV2) and isolated gastric varices (IGV1). The data on the difference between GOV2 and …

Background Peptic ulcer disease (PUD) is more prevalent in cirrhotic patients and it has
been associated with poor outcomes. However, there are no population-based studies from …

The block of the portal flow by obstacles in prehepatic, hepatic or posthepatic site and
alterations of the splanchnic blood flow are the pathological conditions that lead to portal …

BACKGROUND: Terminal liver disease is associated with upper gastrointestinal (GI)
pathology. Following liver transplantation (LT), some immunosuppressive agents can cause …

EDITOR—The study reported by Verhamme et al has several noteworthy limitations. 1
Firstly, the mortality benefit conferred by spironolactone therapy in heart failure has been …